| Primary |
| Product Used For Unknown Indication |
25.0% |
| Stent Placement |
25.0% |
| Drug Use For Unknown Indication |
12.5% |
| Hypertension |
12.5% |
| Thyroid Hormone Replacement Therapy |
12.5% |
| Urticaria |
12.5% |
|
| Nausea |
25.0% |
| Stent Placement |
25.0% |
| Subarachnoid Haemorrhage |
25.0% |
| Systemic Lupus Erythematosus |
25.0% |
|
| Secondary |
| Product Used For Unknown Indication |
24.5% |
| Atrial Fibrillation |
13.7% |
| Cerebrovascular Accident Prophylaxis |
13.2% |
| Blood Pressure |
6.1% |
| Drug Use For Unknown Indication |
5.7% |
| Hypertension |
3.8% |
| Back Pain |
2.8% |
| Cardiac Disorder |
2.8% |
| Pain |
2.8% |
| Parkinson's Disease |
2.8% |
| Supplementation Therapy |
2.8% |
| Thrombosis |
2.8% |
| Anticoagulant Therapy |
2.4% |
| Blood Cholesterol Increased |
2.4% |
| Acute Myocardial Infarction |
1.9% |
| Aggression |
1.9% |
| Blood Cholesterol |
1.9% |
| Blood Cholesterol Abnormal |
1.9% |
| Blood Pressure Abnormal |
1.9% |
| Disturbance In Social Behaviour |
1.9% |
|
| Weight Decreased |
12.2% |
| Tremor |
7.3% |
| Urinary Incontinence |
7.3% |
| Wound Haemorrhage |
7.3% |
| Wrong Technique In Drug Usage Process |
7.3% |
| Drug Ineffective |
4.9% |
| Haematochezia |
4.9% |
| Mouth Haemorrhage |
4.9% |
| Nausea |
4.9% |
| Off Label Use |
4.9% |
| Pain In Extremity |
4.9% |
| Thrombosis |
4.9% |
| Tinnitus |
4.9% |
| Vaginal Haemorrhage |
4.9% |
| Blood Glucose Increased |
2.4% |
| Cardiac Disorder |
2.4% |
| Contusion |
2.4% |
| Drug Hypersensitivity |
2.4% |
| Dyspnoea |
2.4% |
| Epistaxis |
2.4% |
|
| Concomitant |
| Product Used For Unknown Indication |
42.1% |
| Drug Use For Unknown Indication |
7.7% |
| Hypertension |
7.7% |
| Blood Cholesterol Increased |
5.2% |
| Rheumatoid Arthritis |
4.0% |
| Gastrooesophageal Reflux Disease |
3.7% |
| Cardiac Disorder |
3.4% |
| Diabetes Mellitus |
3.1% |
| Pain |
2.9% |
| Osteoporosis |
2.4% |
| Depression |
2.3% |
| Prophylaxis |
2.1% |
| Atrial Fibrillation |
2.0% |
| Type 2 Diabetes Mellitus |
2.0% |
| Chronic Obstructive Pulmonary Disease |
1.8% |
| Vitamin Supplementation |
1.8% |
| Blood Pressure |
1.6% |
| Asthma |
1.5% |
| Multiple Sclerosis |
1.4% |
| Crohn's Disease |
1.4% |
|
| Weight Decreased |
14.3% |
| Weight Increased |
8.0% |
| Pain In Extremity |
7.0% |
| Vomiting |
5.7% |
| Drug Ineffective |
5.5% |
| Pain |
5.5% |
| Off Label Use |
5.1% |
| Wrong Technique In Drug Usage Process |
4.8% |
| Pruritus |
4.7% |
| Pneumonia |
4.2% |
| Rash |
4.1% |
| Nausea |
3.9% |
| Tremor |
3.9% |
| Injection Site Pain |
3.8% |
| Urinary Tract Infection |
3.8% |
| Myocardial Infarction |
3.6% |
| Product Quality Issue |
3.4% |
| Myalgia |
3.1% |
| Muscle Spasms |
2.8% |
| Death |
2.6% |
|
| Interacting |
| Atrial Fibrillation |
11.8% |
| Cardiac Failure Congestive |
11.8% |
| Cerebrovascular Accident Prophylaxis |
11.8% |
| Gastric Disorder |
11.8% |
| Product Used For Unknown Indication |
11.8% |
| Blood Cholesterol Abnormal |
5.9% |
| Blood Pressure Abnormal |
5.9% |
| Cardiac Disorder |
5.9% |
| Diuretic Therapy |
5.9% |
| Gout |
5.9% |
| Heart Rate Decreased |
5.9% |
| Renal Disorder |
5.9% |
|
| Gastritis |
33.3% |
| Subdural Haematoma |
33.3% |
| Weight Decreased |
33.3% |
|
